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ppropriate Use Criteria
nother Step Forward
ut Still a Ways to Go*
odd D. Miller, MD, J. Wells Askew, MD
ochester, Minnesota
ost cardiologists are familiar with appropriate use
riteria (AUC). The American College of Cardiology
oundation (ACCF) has developed AUC for each of the
ajor noninvasive cardiac imaging modalities (1–5). A
andful of studies have examined the application of AUC
n clinical practice (6 –11).
In this issue of the Journal, Hendel et al. (12) report the
esults of the most comprehensive application of the AUC
o date. These authors deserve credit for developing and
romoting AUC. Their current project evaluates the use of
computer-based algorithm to assess the appropriateness of
ingle-photon emission computed tomography myocardial
erfusion imaging (SPECT MPI) in 6,351 patients. As
uch, this study has 2 components that can be analyzed
eparately: 1) the application of this tool in clinical practice;
nd 2) the AUC ratings that were assigned.
See page 156
The first major finding of this study is the demonstration
f the feasibility of prospectively applying AUC using a
omputer-based tool at the point of ordering in a real-world
etting encompassing 6 private practices. This approach was
uccessful, resulting in 93.3% of patients being assigned a
ating category. The novel study design differs from earlier
tudies that retrospectively examined AUC in single aca-
emic medical centers (6–11). Another strength of this
tudy is the use of a computer-based algorithm. Third-party
ayers are more frequently requiring preauthorization by
adiology benefits managers, a process that is time-
onsuming and frustrating for patients and caregivers. A
omputer algorithm should provide a more rapid, objective,
Editorials published in the Journal of the American College of Cardiology reflect the
iew of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
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A limitation of the approach applied by Hendel et al. (12)
oncerns missing data. In the 6.7% of the population that
ould not be assigned an appropriateness indication, the
eason was incomplete data in 75.6%. Coronary heart
isease (CHD) risk could not be calculated in 17% of
atients, and some dates for revascularization procedures
ere not available. The inability to collect complete data for
ommon clinical variables at the point of ordering highlights
hat application of AUC is not necessarily simple.
A second major finding is the distribution of AUC
ategories: 70.7% appropriate, 14.9% uncertain, and 14.4%
nappropriate. The 3 most common indications for per-
orming SPECT MPI (chest pain after revascularization;
hest pain with inability to exercise or uninterpretable
lectrocardiogram; chest pain with intermediate pre-test
robability of CHD, able to exercise, and interpretable
lectrocardiogram) are all rated appropriate and accounted
or nearly half of the studies ordered. Five clinical scenarios
haracterized primarily by asymptomatic status accounted
or 92% of inappropriate studies.
These results are similar to what has been reported at
cademic medical centers (6,7). In these earlier studies,
here was no possibility of altering physician test-ordering
ehavior due to their retrospective study design. However,
n this prospective study (12) it is possible that behavior may
ave been modified. Physicians might have avoided order-
ng inappropriate studies simply in response to knowing that
hey were being monitored (the Hawthorne effect) (13), or
hey could have been actively coached to do so by their
ractice site principal investigator. No information is pro-
ided regarding dissemination of awareness of AUC among
hese practices.
Some unique findings from this study warrant comment.
he prevalence (47.5%) of previous coronary revasculariza-
ion is considerably higher than prevalences of 6% to 34%
eported in previous studies of SPECT MPI (6,7,14,15).
he significance of this observation relates to the applica-
ion of Table 7 (Risk Assessment: Post-Revascularization)
n the SPECT MPI AUC document (1). Only 1 of the 9
linical scenarios listed in this table is rated inappropriate.
hus, simply selecting a population with a high prevalence
f previous revascularization should bias AUC ratings in
avor of fewer inappropriate studies. Another issue relates to
ata from this study that were presented during the Amer-
can College of Cardiology (ACC) 2009 annual meeting but
re not included in this paper. A slide was shown that
emonstrated that CHD risk categories were shifted toward
higher risk based on physicians’ estimates of CHD risk
ersus directly measured CHD risk: high risk, 36% versus
5%; moderate risk, 32% versus 9%; low risk, 32% versus
6% (16). One interpretation of these findings is physicians
elieved that they were referring higher-risk patients for
esting. Because physician behavior may have been altered
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Appropriate Use Criteria January 12, 2010:163–5uring this study, the reported distribution of AUC cate-
ories should be interpreted with caution. This same caveat
pplies to comparisons of cardiologists versus noncardiolo-
ists and physicians within versus those outside the practice.
ncluding control sites where physicians ordering SPECT
PI were unaware of monitoring could have addressed
hese issues but would have necessitated a more complex
tudy design.
Hendel et al. (12) note similarities between the ACCF
UC and the ACC/American Heart Association (AHA)
uidelines. However, the AUC approach is primarily opin-
on based, whereas the guidelines process is more evidence
ased (comprehensive literature review and level-of-
vidence grading scheme). Several apparent discrepancies
xist for clinical scenarios rated appropriate by AUC but
ssigned a Class IIb or III indication by the guidelines.
valuation of symptomatic patients at intermediate or high
re-test probability of CHD who have an interpretable
lectrocardiogram and are able to exercise is an example.
CC/AHA guidelines (17) assign stress imaging a Class
Ib indication as the initial test in this setting because
tandard treadmill testing can accurately risk stratify the
ajority of these patients and is lower cost. Another
xample includes risk stratification of asymptomatic diabetic
atients. AUC designate diabetes status as high CHD risk
nd, therefore, assign a rating of appropriate to SPECT
PI for screening purposes in all diabetic patients. Al-
hough several studies have demonstrated that SPECT
PI can risk stratify asymptomatic diabetic patients (18),
uidelines assign ratings of Class IIb or III because no study
as shown that routine application of stress imaging in this
etting leads to improved patient outcome, including the
ecently published DIAD (Detection of Ischemia in
symptomatic Diabetics) trial (19). If AUC adopted a more
vidence-based guidelines approach, the distribution of
UC categories in this study (12) would have shifted
oward more inappropriate studies.
The actual number of inappropriate cardiac imaging studies
eing performed in the U.S. remains unknown. Between 1993
nd 2001, the rate of growth of stress imaging was steep (6%
nnually) and far exceeded modest rates of growth of coronary
ngiography or revascularization, whereas the incidence of
yocardial infarction was constant (20). These findings sug-
est that the number of normal SPECT MPI studies has
ramatically increased, likely due to expanded use of imaging
n low-risk patients. A recent publication implies that self-
eferral has contributed to this growth. Private office use of
PECT MPI by cardiologists increased 215% and Medicare
art B payments to cardiologists increased 301% between 1998
nd 2006 (21).
We believe that the AUC process could be improved by
ddressing the following issues. 1) The formal definition of
appropriate” (22) should be revised to incorporate financial
ost as a negative consequence of performing an inappro-
riate study. 2) Rating panels should be more heterogeneous
nd include more nonimagers to achieve better balance inhe voting process. 3) AUC clinical scenarios included for
ating assignments should be reassessed, eliminating “straw
an” indications that are never used (e.g., resting SPECT
PI in acute ST-segment elevation myocardial infarction)
1) and instead including common uses in practice that are
ot addressed (e.g., resting echocardiogram for determina-
ion of ejection fraction in a patient with chest pain and a
ormal electrocardiogram) (4). 4) The AUC ratings process
hould be more rigorous. AUC voting panels are instructed
o assign a rating of appropriate if imaging is “reasonable” to
erform for a given clinical scenario. A rating assignment of
ppropriate should be supported by medical evidence.
Noninvasive imaging plays a major role in the evaluation
nd management of patients with CHD. The most efficient
se of noninvasive testing involves matching the right test to
he right patient. The rapid rate of growth of cardiac
maging suggests overuse, creating waste in the medical
ystem. Controlling costs by selectively eliminating expen-
ive imaging procedures in low-risk patients should be much
ore palatable to patients and physicians than draconian
cross-the-board reductions in reimbursement enacted by
he Centers for Medicare and Medicaid Services. An
nfortunate consequence of this latter approach is denial of
maging procedures to higher-risk patients who can clearly
enefit from this technology. Hendel et al. (12) have
emonstrated a practical and efficient method to facilitate
pplication of AUC in clinical practice. Strengthening the
UC ratings process would enhance the credibility of using
UC to control medical costs.
eprint requests and correspondence: Dr. Todd D. Miller,
ayo Clinic, Gonda 5-412, 200 First Street SW, Rochester,
innesota. E-mail: miller.todd@mayo.edu.
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